Header image alt text

Niu Huang's Lab

@NIBS

Classic papers->Medicinal Chemistry

Posted by admin on June 16, 2017
Posted in news 

 Classic papers
 2006
     
Title Author Cited
RA Friesner, RB Murphy, MP Repasky… – Journal of medicinal …, 2006
1728
GL Warren, CW Andrews, AM Capelli… – Journal of medicinal …, 2006
1230
N Huang, BK Shoichet, JJ Irwin – Journal of medicinal chemistry, 2006
920
W Sherman, T Day, MP Jacobson… – Journal of medicinal …, 2006
897
J Wang, SM Soisson, K Young, W Shoop, S Kodali… – Nature, 2006
680
K Ding, Y Lu, Z Nikolovska-Coleska… – Journal of medicinal …, 2006
512
M Matsumoto, H Hashizume, T Tomishige… – PLoS Med, 2006
No profilesNo profiles
491
HA Overton, AJ Babbs, SM Doel, MCT Fyfe… – Cell …, 2006
No profilesNo profiles
476
MS Karthikeyan, DJ Prasad, B Poojary… – … & medicinal chemistry, 2006
436
M Whiting, J Muldoon, YC Lin… – Angewandte Chemie …, 2006
427
Dates and citation counts are estimated and are determined automatically by a computer program.
 
 

CryoEM structure of yeast cytoplasmic exosome complex.

Posted by admin on December 12, 2016
Posted in news 

jcim

JMC_ZhouYu

20140809_神道2 AstraZeneca is a Global, Biopharmaceutical Company with Research and Development at its Core. The AstraZeneca Open Innovation platform has been created to identify and establish mutually beneficial collaborations that will lead to the discovery and development of new medicines. It provides a robust but simple process for link their expertise, experience, resources, and technology with those of external experts and to explore prospective partnerships that accelerate the advancement of medical science and breakthrough therapies for patients. And the postdoctoral academic institutions of the selected researchers will receive funding to support the corresponding researches for up to three years.